Alkem Laboratories has announced that the United States Food and Drug Administration (US FDA) conducted a Bioresearch Monitoring (BIMO) inspection at the company's Bioequivalence Centre in Taloja, Maharashtra.
The inspection took place from March 10, 2025, to March 13, 2025. The company has requested stakeholders to take this update on record.